Furthermore, treatment-naïve RA patients were shown to bare higher serum levels of TREM-1 compared to RA patients treated by disease-modifying anti-rheumatic drugs (DMARDs)12. This evidence concerns the gene TREM1 and rheumatoid arthritis.